|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Ceftobiprole>> Market Analysis Reports |
Market Analysis Reports of Ceftobiprole |
|
Global Market Report of Ceftobiprole (CAS 209467-52-7) December 2024 Global Market Report of Ceftobiprole medocaril (CAS 376653-43-9) December 2024 CAS 376653-43-9 Ceftobiprole medocaril Chemical Report & Database ... Report & Database This Ceftobiprole medocaril Chemical World Consumption ... & Database definitions: Name: Ceftobiprole medocaril: Ceftobiprole medocaril Chemical Registry ... Chemical or Reaction Intermediate The Ceftobiprole medocaril Report & Database gives ... Basilea Pharmaceutica AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... of clinical development. Products BAL5788 Ceftobiprole (BAL5788), anti-MRSA cephalosporins with ... the companys antibiotic compound ceftobiprole (BAL5788). Under this agreement ... retains the option to co-promote ceftobiprole in major market countries. History ... Achillion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... ; oritavancin by Intermune; doripenem by Johnson & Johnson; ceftobiprole by Basilea and Johnson & Johnson; iclaprim ... Global Antibacterial Drug Resistance Industry Research Report 2020, Forecast to 2025 ... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin ... Global Antibacterial Drug Resistance Market Insight 2020, Forecast to 2025 ... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin ... Complicated skin and soft tissue infections (cSSTI) - Pipeline Insight, 2021 ... treatment of cSSTI. Ceftobiprole medocaril: Basilea Pharmaceutica Ceftobiprole medocaril, the ... of the active moiety ceftobiprole, is a cephalosporin antibiotic for intravenous ... North Africa (MENA) region. Ceftobiprole is currently in phase 3 clinical ... Global Antibacterial (Drug) Resistance Market Report 2020 ... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin ... Global Antibacterial (Drug) Resistance Market Growth 2023-2029 ... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin ... Global Antibacterial (Drug) Resistance Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin ... Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H1 2020 Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Susceptible Staphylococcus aureus Infections – Pipeline ... Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2020 Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Susceptible Staphylococcus aureus Infections - Pipeline ... Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) - Drugs in Development, 2021 Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Susceptible Staphylococcus aureus ... Global Cephalosporin Drugs Market Size Study & Forecast, by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation), by Prescription (Prescription Drugs, OTC Drugs), and Regional Analysis, 2023-2030 ... July 2022, Mast introduced Ceftobiprole 5µg to its MASTDISCS Antimicrobial Susceptibility ... Test range. Ceftobiprole (Zevtera/Mabelio) is a 5th generation Cephalosporin ... and a favorable safety profile, Ceftobiprole is a valuable option for ... Global Antibacterial (Drug) Resistance Market Status, Trends and COVID-19 Impact Report 2021 ... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin ... Antibacterial Drugs: Market Research Report This report analyzes the worldwide markets for Antibacterial Drugs in US$ Million by the following drug classes: Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, and Other Antibacterial Drugs. The report provides separate comprehensive analytics ... Acute Bacterial Skin and Skin Structure Infections - Pipeline Insight, 2021 ... Drugs Zevtera: Basilea Pharmaceutica Zevtera (Ceftobiprole medocaril), the prodrug of the active ... moiety ceftobiprole, is a cephalosporin antibiotic for intravenous administration ... Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide ... Anti-Infectives: Market Research Report This report analyzes the worldwide markets for Anti-Infectives in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. ... |